Cervical Cancer Diagnostic Test Market (Pap Smear Tests, Colposcopy, HPV Testing, Endocervical Curettage (ECC) and Others) for Hospitals, Laboratories and Other End-users - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends and Forecast, 2015 – 2021

Global cervical cancer diagnostic market expected to reach USD 9.46 by 2021, growing at a CAGR of 5.9% between 2015 and 2021.

19-Sep-2016 | Number of pages: 110 | Report Code: ZMR-164 | Report Format : | Status : Published

Abstract

The report covers forecast and analysis for the cervical cancer diagnostic test market on a global and regional level. The study provides historic data of 2015 along with a forecast from 2016 to 2021 based on revenue (USD Billion). The study includes drivers and restraints for the cervical cancer diagnostic test market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the cervical cancer diagnostic test market on a global level.

This report offers comprehensive coverage on global cervical cancer diagnostic test market along with market trends, drivers, and restraints of cervical cancer diagnostic test market. This report included a detailed competitive scenario and product portfolio of key vendors. To understand the competitive landscape in the market, an analysis of Porter’s five forces model for the cervical cancer diagnostic test market has also been included. The study encompasses a market attractiveness analysis, wherein all segments are benchmarked based on their market size, growth rate, and general attractiveness. This report is prepared using data sourced from in-house databases, secondary and primary research team of industry experts.

The study provides a decisive view on the cervical cancer diagnostic test market by segmenting the market based on the type of test, end- users and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2015 to 2021. The test type market covered under this study includes Pap smear tests, colposcopy, HPV testing, endocervical curettage (ECC) and others (cone biopsy and loop electrosurgical excision procedure). The end-user segment includes hospitals, laboratories, and others. The regional segmentation includes the current and forecast demand for North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. These regions are further segmented into the U.S., UK, Germany, France, Japan, China, India and Brazil.  

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global cervical cancer diagnostic test market include Abbott Laboratories, Becton, Dickinson and Company, Femasys, Inc., Hologic, Inc., Guided Therapeutics, Inc., OncoHealth Corp., Quest Diagnostics, Inc., Roche Diagnostics, QIAGEN, and Zilico Ltd.

This report segments the global cervical cancer diagnostic test market as follows:

Global Cervical Cancer Diagnostic Test Market: Test Analysis

  • Pap Smear Tests
  • Colposcopy
  • HPV Testing
  • Endocervical Curettage (ECC)
  • Others {Cone Biopsy and Loop Electrosurgical Excision Procedure (LEEP)

Global Cervical Cancer Diagnostic Test Market: End- User Analysis

  • Hospitals
  • Laboratories 
  • Others

Global Cervical Cancer Diagnostic Test Market: Regional Segment Analysis

  • North America
    • US
  • Europe
    • UK
    • Germany
    • France 
  • Asia Pacific
    • China 
    • Japan 
    • India
  • Latin America
    • Brazil
  • Middle East And Africa

Related Reports

Hysteroscopic Endometrial Resection Procedures Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2285 | Report Format:

Hysteroscopic Endometrial Resection Procedures Market: Overview Hysteroscopic endometrial resection procedure is a treatment for the women that have problems with heavy menstrual bleeding and also for the women who wish to no longer have children. This treatment is very effective. The hysterosco...Read More

Home Infusion Therapy Market by Product (Infusion Pump, Intravenous Sets, IV Cannulas, Needleless Connectors) by Application (Anti-Infectives, Endocrinology, Enteral nutrition, Hydration Therapy, Parenteral Nutrition): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022

Sep-2017 | Price : $ 4199.00 | Pages: 110 | Report Code: ZMR-2278 | Report Format:

The report covers forecast and analysis for the home infusion therapy market on a global and regional level. The study provides historic data of 2014 and 2015 along with a forecast from 2016 to 2022 based revenue (USD Billion). The study includes drivers and restraints for the home infusion therap...Read More

Laser Printable Wristbands Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2272 | Report Format:

Laser Printable Wristbands Market: Growth Factors The developments that are made in the healthcare technology is the major factor that is driving the laser printable wristbands market. The companies are making increased use of the laser printable wristbands for several purposes owing to the fact...Read More

Microsclerotherapy Treatment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2208 | Report Format:

Microsclerotherapy Treatment Market: Overview For the treatment of the spider veins, microsclerotherapy is one of the best treatment options. In this treatment, the sclerosant is injected into the body which helps in destroying the veins in a period of time and gradually disappears. The most com...Read More

Remicade Biosimilar Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Price : $ 3599.00 | Report Code: ZMR-2197 | Report Format:

Remicade Biosimilar Market: Overview Biosimilar is a term that is used to define a biological product type that is very much similar to the drug that is already approved by the FDA; this product is known as the reference biological product. The Remicade is an antibody that is monoclonal and is u...Read More

Choose License Type:
Latest Published Reports

View All Published Reports